Company / EPS (Diluted)
Immunocore Holdings plc EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.13
FY2025
5-year range
-$4.24 / -$1.13
FY2021-FY2025
Trend
+1.7%
vs FY2024
Sector context
#93 of 204
Health Care
What the data says
At $-1.13, Immunocore Holdings plc's eps (diluted) ranks #93 of 204 in the Health Care sector. Improved from $-4.24 to $-1.13 over the past 2 years.
Based on SEC 10-K filings.
-1.13 in FY2025.
Improved from $-4.24 to $-1.13 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 204 in Health CareTop 46% of 204This company -$1.13 Sector average -$0.89
▼
-27.5% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 1.7% year-over-year.
- Ranks #93 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.13 | +1.7% |
| FY2024 | -$1.15 | +72.9% |
| FY2023 | -$4.24 | -268.7% |
| FY2022 | -$1.15 | +72.9% |
| FY2021 | -$4.24 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026